Freebird Partners LP

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Houston, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Freebird Partners LP, By: Freebird Investments LLC, its general partner, By: /s/ Curtis W. Huff, Chairman and President
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Freebird Partners LP

Form 4 holding 10%+ Owner

Eterna Therapeutics Inc.

Security class
Convertible Note Shares
Shares / value
783,233
Estimated value
$1,503,337
Report date
15 Dec 2023
Price
$1.92
Ownership
Direct
Underlying class
Common Stock, par value $0.005 per share
Underlying amount
Form 4 holding 10%+ Owner

Comera Life Sciences Holdings, Inc.

Security class
Convertible Note Shares
Shares / value
2,453,636
Estimated value
$134,950
Report date
29 Dec 2023
Price
$0.0550
Ownership
Direct
Underlying class
Common Stock, par value $0.0001 per share
Underlying amount
Form 4 holding 10%+ Owner

Comera Life Sciences Holdings, Inc.

Security class
Common Stock Purchase Warrant
Shares / value
7,362,005
Estimated value
Report date
29 Dec 2023
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.0001 per share
Underlying amount
Form 4 holding 10%+ Owner

Eterna Therapeutics Inc.

Security class
Common Stock Purchase Warrant
Shares / value
1,991,394
Estimated value
Report date
15 Dec 2023
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.005 per share
Underlying amount

Insider Reports Filed by Freebird Partners LP

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .